Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA

BACKGROUND AND AIMS: A functional cure, or hepatitis B virus (HBV) surface antigen (HBsAg) loss, is difficult to achieve in patients with hepatitis B virus e antigen (HBeAg)-positive chronic hepatitis B. The HBV vaccine and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Hongyu, Yu, Guodong, Yu, Jiong, Zhang, Xiaoli, Yang, Lisha, Wang, Bin, Zhang, Jiming, Bai, Lang, Zhang, Xinxin, Wang, Kai, Zhao, Ping, Yang, Dongliang, Zhao, Yingren, Yu, Yanyan, Zhang, Yimin, Gu, Jueqing, Ye, Chanyuan, Cai, Huan, Lu, Yingfeng, Xiang, Dairong, Yu, Liang, Lian, Jiangshan, Hu, Jianhua, Zhang, Shanyan, Jin, Ciliang, Yang, Yida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412713/
https://www.ncbi.nlm.nih.gov/pubmed/37577218
http://dx.doi.org/10.14218/JCTH.2022.00413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412713/
https://www.ncbi.nlm.nih.gov/pubmed/37577218
http://dx.doi.org/10.14218/JCTH.2022.00413

Ejemplares similares